Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:FEMY NASDAQ:SKIN NASDAQ:SLNO NASDAQ:SPAI On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeFEMYFemasys$0.35-2.1%$0.44$0.31▼$1.11$21.66M-2.26439,448 shs577,109 shsSKINBeauty Health$0.68+2.3%$0.91$0.55▼$2.69$85.86M1.121.33 million shs1.25 million shsSLNOSoleno Therapeutics$53.01$45.79$29.43▼$90.32$2.76B-2.221.75 million shsN/ASPAISafe Pro Group$3.95-1.3%$4.31$2.39▼$9.16$83.54M3432,550 shs179,637 shs7 Stocks That Will Be Magnificent in 2026Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceFEMYFemasys-2.06%-7.92%-17.25%-35.68%-67.48%SKINBeauty Health+2.26%+4.23%-23.30%-31.04%-59.91%SLNOSoleno Therapeutics0.00%+0.11%+0.65%+34.51%-29.37%SPAISafe Pro Group-1.25%-6.18%-11.43%-7.93%+38.60%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeFEMYFemasys$0.35-2.1%$0.44$0.31▼$1.11$21.66M-2.26439,448 shs577,109 shsSKINBeauty Health$0.68+2.3%$0.91$0.55▼$2.69$85.86M1.121.33 million shs1.25 million shsSLNOSoleno Therapeutics$53.01$45.79$29.43▼$90.32$2.76B-2.221.75 million shsN/ASPAISafe Pro Group$3.95-1.3%$4.31$2.39▼$9.16$83.54M3432,550 shs179,637 shs7 Stocks That Will Be Magnificent in 2026Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceFEMYFemasys-2.06%-7.92%-17.25%-35.68%-67.48%SKINBeauty Health+2.26%+4.23%-23.30%-31.04%-59.91%SLNOSoleno Therapeutics0.00%+0.11%+0.65%+34.51%-29.37%SPAISafe Pro Group-1.25%-6.18%-11.43%-7.93%+38.60%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceFEMYFemasys 2.50Moderate Buy$5.331,418.60% UpsideSKINBeauty Health 2.00Hold$2.02198.15% UpsideSLNOSoleno Therapeutics 2.08Hold$76.6744.63% UpsideSPAISafe Pro Group 2.60Moderate Buy$10.00153.16% UpsideCurrent Analyst Ratings BreakdownLatest FEMY, SLNO, SKIN, and SPAI Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/20/2026SKINBeauty Health Roth MkmSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy$2.50 ➝ $2.005/19/2026SLNOSoleno Therapeutics Cantor FitzgeraldSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingNeutral5/18/2026FEMYFemasys Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeSell (D-) ➝ Sell (E+)5/11/2026SLNOSoleno Therapeutics Zacks ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeHold ➝ Strong Sell5/1/2026FEMYFemasys Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeSell (E+) ➝ Sell (D-)5/1/2026SKINBeauty Health Canaccord Genuity GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetHold$1.50 ➝ $1.004/21/2026SPAISafe Pro Group Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D-)4/17/2026SLNOSoleno Therapeutics Wells Fargo & CompanySubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingSet Price TargetOverweight ➝ Equal Weight$110.00 ➝ $53.004/17/2026SLNOSoleno Therapeutics Wells Fargo & CompanySubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeOverweight ➝ Equal Weight$110.00 ➝ $53.004/8/2026SLNOSoleno Therapeutics HC WainwrightSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeBuy ➝ Hold$100.00 ➝ $53.004/7/2026SLNOSoleno Therapeutics Piper SandlerSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeStrong-Buy ➝ Hold(Data available from 5/21/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookFEMYFemasys$2.29M9.26N/AN/A$0.12 per share2.93SKINBeauty Health$296.12M0.30$0.16 per share4.34$0.43 per share1.58SLNOSoleno Therapeutics$285.01M9.69$0.43 per share124.10$9.51 per share5.57SPAISafe Pro Group$610K135.27N/AN/A$0.74 per share5.34Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateFEMYFemasys-$18.63M-$0.27N/AN/AN/A-521.97%-258.08%-73.72%N/ASKINBeauty Health-$9.52M-$0.17N/AN/AN/A-2.03%-9.38%-1.21%8/6/2026 (Estimated)SLNOSoleno Therapeutics$20.89M$1.7729.959.89N/A33.70%22.85%18.25%8/5/2026 (Estimated)SPAISafe Pro Group-$14.32M-$0.71N/AN/AN/A-800.91%-119.17%-107.17%5/21/2026 (Estimated)Latest FEMY, SLNO, SKIN, and SPAI EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/15/2026Q1 2026SPAISafe Pro Group-$0.15-$0.14+$0.01-$0.14$1.01 million$1.22 million5/8/2026Q1 2026FEMYFemasys-$0.0667$0.0049+$0.0716N/A$0.77 million$0.42 million5/7/2026Q1 2026SKINBeauty Health-$0.09-$0.05+$0.04-$0.05$66.28 million$64.91 million3/31/2026Q4 2025FEMYFemasys-$0.0833-$0.01+$0.0733-$0.01$1.06 million$0.81 million3/31/2026Q4 2025SPAISafe Pro Group-$0.10-$0.15-$0.05-$0.16$0.10 million$0.23 million3/12/2026Q4 2025SKINBeauty Health-$0.07-$0.06+$0.01-$0.06$78.07 million$82.37 million2/25/2026Q4 2025SLNOSoleno Therapeutics$0.64$0.80+$0.16$0.80$88.55 million$91.73 millionCompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthFEMYFemasysN/AN/AN/AN/AN/ASKINBeauty HealthN/AN/AN/AN/AN/ASLNOSoleno TherapeuticsN/AN/AN/AN/AN/ASPAISafe Pro GroupN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioFEMYFemasys0.533.911.98SKINBeauty Health4.371.791.48SLNOSoleno Therapeutics0.105.625.32SPAISafe Pro Group0.0113.2713.84Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipFEMYFemasys65.27%SKINBeauty Health93.26%SLNOSoleno Therapeutics97.42%SPAISafe Pro GroupN/AInsider OwnershipCompanyInsider OwnershipFEMYFemasys7.55%SKINBeauty Health40.30%SLNOSoleno Therapeutics6.40%SPAISafe Pro Group54.80%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableFEMYFemasys3060.39 million55.83 millionNot OptionableSKINBeauty Health1,030129.60 million77.37 millionOptionableSLNOSoleno Therapeutics3052.12 million48.78 millionOptionableSPAISafe Pro Group1120.89 million9.44 millionN/AFEMY, SLNO, SKIN, and SPAI HeadlinesRecent News About These CompaniesSafe Pro Group (NASDAQ: SPAI) Advances Edge AI Threat Detection Collaboration With Lantronix3 hours ago | theglobeandmail.comSafe Pro and Lantronix Advance Their Collaboration Delivering AI-Driven Edge Intelligence for Defense and Commercial Autonomous SystemsMay 20 at 8:02 AM | globenewswire.comSafe Pro Group (NASDAQ: SPAI) Secures Additional U.S. Government Subcontract Support for AI Edge Processing SolutionMay 19 at 12:04 AM | theglobeandmail.comSafe Pro Group (NASDAQ: SPAI) to Demonstrate AI-Powered InFlight Threat Detection Integrated into Red Cat Black Widow(TM) Drones for U.S. ArmyMay 19 at 12:04 AM | theglobeandmail.comSafe Pro and Red Cat to Unveil InFlight Real-Time AI Threat Detection Capabilities to the U.S. Army Onboard the Black Widow™ Drone PlatformMay 19 at 8:45 AM | globenewswire.comSafe Pro Awarded Additional U.S. Government Subcontract Modification for Extended Support of AI ...May 18 at 8:58 AM | caledonianrecord.comCSafe Pro Group Inc. Secures Subcontract Modification for AI Edge Processing Solution with U.S. GovernmentMay 18 at 8:31 AM | quiverquant.comQSafe Pro Awarded Additional U.S. Government Subcontract Modification for Extended Support of AI Powered Edge Processing SystemsMay 18 at 8:02 AM | globenewswire.comSafe Pro Group Inc. (NASDAQ:SPAI) Given Consensus Rating of "Moderate Buy" by AnalystsMay 18 at 4:17 AM | americanbankingnews.comSafe Pro Group Inc.: Safe Pro Reports Record 560% Revenue Growth in First Quarter as Artificial Intelligence Sales Surge 2,400%, Delivering AI Gross Margins Over 72%May 16, 2026 | finanznachrichten.deSafe Pro Group (NASDAQ: SPAI) Reports Record First-Quarter Revenue Growth Driven by AI Defense SolutionsMay 16, 2026 | theglobeandmail.comSafe Pro Group Inc. (SPAI) Reports Q1 Loss, Beats Revenue EstimatesMay 15, 2026 | zacks.comSafe Pro Group Inc. : SPAIMay 15, 2026 | 247wallst.comSafe Pro Reports Record 560% Revenue Growth in First Quarter as Artificial Intelligence Sales Surge 2,400%, Delivering AI Gross Margins Over 72%May 15, 2026 | globenewswire.comSafe Pro Group, Inc. (SPAI) Gets a Buy from Lake StreetMay 14, 2026 | theglobeandmail.comSPARC AI Inc. (OTC: SPAIF) Leading Out in Filling Gap, Developing Software-Only Drone SystemMay 14, 2026 | globenewswire.comSafe Pro Group (SPAI) Expected to Announce Earnings on ThursdayMay 14, 2026 | americanbankingnews.comSPARC AI Inc. (OTC: SPAIF) Developing Software-Only Platform Designed to Overcome Key Drone LimitationMay 12, 2026 | globenewswire.comSafe Pro Group (NASDAQ: SPAI) Selected for U.S. Army Force-on-Force Combat Training ExerciseMay 11, 2026 | theglobeandmail.comSafe Pro’s Edge AI Battlefield Threat Detection Selected by U.S. Army for Upcoming ...May 11, 2026 | caledonianrecord.comCSafe Pro Group Inc. (NASDAQ:SPAI) Short Interest Down 27.2% in AprilApril 29, 2026 | marketbeat.comNew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All HeadlinesThe Real SpaceX Play: 5 Chip Stocks Powering the IPO Before It LaunchesBy Bridget Bennett | May 4, 2026AMD’s Breakout Isn’t the Story—This Catalyst IsBy Thomas Hughes | April 24, 2026Apple Talks Just Changed Everything for IntelBy Sam Quirke | May 6, 20263 Energy Stocks to Buy and 2 to Avoid as AI Power Demand ExplodesBy Bridget Bennett | May 4, 2026Vertical Aerospace: Pre-Flight Checks Point to a BreakoutBy Jeffrey Neal Johnson | May 20, 2026FEMY, SLNO, SKIN, and SPAI Company DescriptionsFemasys NASDAQ:FEMY$0.35 -0.01 (-2.06%) Closing price 05/20/2026 04:00 PM EasternExtended Trading$0.35 +0.00 (+0.51%) As of 05/20/2026 07:39 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Femasys Inc., a biomedical company, develops therapeutic and diagnostic solutions to address unmet women healthcare needs worldwide. The company provides FemVue saline-air device, a contrast-generating product in the United States, Canada, Japan, and Hong Kong; FemCath, a cornual balloon catheter, a single intrauterine directional delivery product that allows for selective evaluation of an individual fallopian tube; and FemCerv, a biopsy device for endocervical curettage, which can be used to sample cervical cells and tissue circumferentially with sample containment within the device to minimize contamination. It also develops permanent birth control solutions, such as FemBloc and FemChec; FemaSeed, an artificial insemination solution; and FemEMB, a product candidate for endometrial sampling in support of uterine cancer detection testing. The company offers its products to reproductive endocrinologists for infertility products, obstetrics-gynecological physicians, related healthcare professionals, and women's healthcare provider organizations. Femasys Inc. was incorporated in 2004 and is headquartered in Suwanee, Georgia.Beauty Health NASDAQ:SKIN$0.68 +0.02 (+2.26%) Closing price 05/20/2026 04:00 PM EasternExtended Trading$0.69 +0.01 (+1.25%) As of 05/20/2026 07:35 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.The Beauty Health Company designs, develops, manufactures, markets, and sells aesthetic technologies and products worldwide. The company's flagship product includes HydraFacial that enhance the skin to cleanse, extract, and hydrate the skin with proprietary solutions and serums. Its products also comprise Syndeo, a Delivery System designs to connects providers to the consumer's preferences to create a more personalized experience; consumables, such as single-use tips, solutions, and serums used to provide a hydrafacial treatment; SkinStylus SteriLock Microsystem, a microneedling device used for the treatment of enhancing appearance of surgical or traumatic hypertrophic scars on the abdomen and facial acne scarring in Fitzpatrick skin types I, II, and III; and Keravive, a treatment for scalp health. The company was founded in 1997 and is headquartered in Long Beach, California.Soleno Therapeutics NASDAQ:SLNO$53.01 0.00 (0.00%) As of 05/19/2026Soleno Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its lead candidate is Diazoxide Choline Extended-Release tablets, a once-daily oral tablet, which is in Phase III clinical trials for the treatment of Prader-Willi Syndrome. The company was formerly known as Capnia, Inc. and changed its name to Soleno Therapeutics, Inc. in May 2017. Soleno Therapeutics, Inc. was incorporated in 1999 and is based in Redwood City, California.Safe Pro Group NASDAQ:SPAI$3.95 -0.05 (-1.25%) Closing price 05/20/2026 04:00 PM EasternExtended Trading$3.86 -0.10 (-2.41%) As of 05/20/2026 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Safe Pro Group, Inc. engages in the provision and acquisition of security and protection products. Its products include Artificial Intelligence (AI) and Machine Learning (ML) software technology and photogrammetry analysis tools, bullet and blast resistant personal protection equipment, and aerial managed services and mission-critical uncrewed solutions. The firm operates through the following segments: Safe-PRO USA, Airborne Response, and Safe Pro AI. The company was founded by Daniyel Erdberg on December 15, 2021 and is headquartered in Aventura, FL. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Analog Devices Provides Much-Needed Pullback: How Low Can It Go? USA Rare Earth Posts Strong Q1 2026 as Massive Serra Vera Deal Looms From Zepbound to Foundayo: Lilly's Latest Results Support Oral GLP-1 Outlook AI Consolidation Begins: Blackstone & Google Forge an AI Empire The Great AI Rotation: Cashing In on Data Mirum Pharma: A Rare Disease Growth Story to Watch Vertical Aerospace: Pre-Flight Checks Point to a Breakout HIVE Weaponizes Power for an AI Pivot Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
